Contact us

About Intavis Peptide Services

Leadership

Our leadership team at Intavis Peptide Services has extensive experience in the biotech space, with a proven track record of launching new ventures and developing innovative peptide synthesis methods. We are experts in peptide and protein chemistry, and we are passionate about using our knowledge and expertise to serve our customers and stakeholders.

At Intavis Peptide Services, we are dedicated to improving the lives of patients through our hands-on, collaborative approach with researchers and healthcare professionals alike. Trust us to deliver the most effective and innovative peptide solutions for your research.

Dr. Steffen Hüttner

CEO Learn More

Alexander Paasch

CFO Learn More

Felix Niethammer

CSO Learn More

Karin Klass

COO Learn More

Dr. Christian Stumpp

HoBD Learn More

Dr. Peter Lewandrowski

HoQM Learn More

Dr. Holger Eickhoff

HoP Learn More

Well advised and connected Partners & Advisors

We are excited to introduce you to our valued partners and scientific advisors, who bring decades of experience and expertise in the start-up, peptide and oncology space. Their extensive knowledge and insights help us achieve greater success in meeting our clients’ needs and pushing the frontier of personalized peptide therapies. We are proud to have them on board and we continue to collaborate towards a brighter future in healthcare.

Dr. Dirk Biskup

Advisor

Dr. Dr. Saskia Biskup

Advisor

Dr. Klaus Maleck

Partner

History

2005

Establishment of the Peptide Synthesis Laboratory in the “Technologiepark Heidelberg”, initially for testing parallel peptide synthesis technology.

2006

Acquisition of Intavis Bioanalytical Instruments by HB-Technologies AG, including the first office in the US.

2010

Collaboration with NMI Tübingen and integration of the peptide synthesis group of NMI TT GmbH.

2015

Relocation and consolidation of both laboratory locations at Waldhäuser Strasse 64, Tübingen, Germany.Integration of Intavis Bioanalytical Instruments AG into the HB-Technologies group.

2019

Spin-off from HB-Technologies group as IntavisPeptide Services GmbH.

2020

Incorporation of Intavis Bioanalytical Instruments AG into HB-Technolgies AG; Decision to build a GMPpeptide synthesis facility in Tübingen.

2021

Dr. Dr. Saskia Biskup, Dr. Dirk Biskup, and Dr. Klaus Maleck join the company as partners.

2022

Entry of additional shareholders and completion of financing round.

Laboratory
research

Easy, reliable and cost-effective

Find out more

GMP-grade
Peptides

Customized at the highest standard

Find out more
Coming in 2024

Fill & Finish

Tailored Fill & Finish

Find out more
Coming in 2024

Peptides tailored to your research Order your peptides

Click order and a form will pop-up so you can enter your sequence directly. Alternatively upload a document listing your peptides or conjugates.